A voice for
herbal medicine

We share traditional, scientific and practical insights written by experienced herbalists and health experts from the world of herbal medicine and natural health

← Back to Insights

Supporting doctors: How herbs can help reduce opioid use in chronic pain

  • Dr. Amparo Aracil
    Dr. Amparo Aracil

    Amparo is a medical herbalist and doctor interested in community herbalism and acute medicine. Amparo combines their work as a herbalist with working as a doctor, previously for the NHS and now in both primary care and A&E in Spain. Amparo has also worked with Herbalists Without Borders Calais providing first aid and herbal medicine to migrants and refugees. Having a special interest in psychoneuroimmunology and auto-immune conditions, they have extensive clinical experience helping people with ulcerative colitis, Crohn’s disease, rheumatoid arthritis and thyroid disorders.

    Amparo has been involved with writing lectures and teaching clinical skills for Heartwood students, and runs student clinics on a monthly basis.

    Amparo is a registered member of the National Institute of Medical Herbalists and the General Medical Council. You can find more about them at their website.

  • 10:06 reading time (ish)
  • Western herbal medicine

Opioid drugs are effective analgesia for acute conditions, yet bring risk of tolerance and dependency from long-term use. What does herbal medicine have to offer in the treatment of chronic pain?

The overuse of opioids in treating chronic non-cancer pain is a growing concern worldwide, particularly in the United Kingdom (12). The NHS England Medicines Optimisation Executive Group (MOEG) has identified reducing opioid use in this context as a key national priority for 2023/24 (3). Chronic non-cancer pain*, affecting millions in the UK, is often managed through opioids despite their limited efficacy and significant risk of dependence, tolerance, and other adverse effects (2,4). There is a potential role for herbal medicine to help reduce opioid use, thus supporting doctors in pain management.

*Throughout this article, when discussing “chronic pain”, we are referring to chronic non-cancer pain (CNCP).

The opioid crisis in the UK and its challenges

Supporting doctors How herbs can help reduce opioid use in chronic pain

Opioids, including tramadol, morphine, oxycodone, and fentanyl, are commonly prescribed for chronic pain. However, there is growing evidence that they are not particularly effective for long-term pain management in non-cancer patients (4,5,6). A systematic review highlighted that opioids provide only modest pain relief and little improvement in function for chronic pain patients, often leading to significant adverse effects, such as gastrointestinal issues, dizziness, and, most critically, dependency and addiction (4). In the UK, the Office for National Statistics (ONS) reported over 4,000 deaths related to opioid use in 2022 alone, underscoring the urgent need for safer pain management strategies (7).

Furthermore, the pharmacological treatment of chronic pain offers limited benefits and may pose potential risks, especially when compared to effective biopsychosocial interventions. The evidence supporting the use of strong opioids for chronic pain is inadequate to justify their use for this purpose (6). However, it is recognised that due to dependency, many individuals may struggle to discontinue these medications.

Given these challenges, the NHS Medicines Optimisation Executive Group has prioritised reducing opioid use to treat chronic pain. Traditional pharmacological interventions often fall short of providing long-term relief, prompting a growing interest in integrative approaches, including the use of herbal medicine (8).

Dr. Amparo Aracil

Amparo is a medical herbalist and doctor interested in community herbalism and acute medicine. Amparo combines their work as a herbalist with working as a doctor, previously for the NHS and now in... Read more

Sign up to our Newsletter

Sign up to our newsletter to receive the very latest in herbal insights.

Sign up to our newsletter